Market research reports, consulting: Global Market Insights Inc.

Home > Healthcare > Pharmaceuticals > Finished Drug Form > liver cancer drugs market

Liver Cancer Drugs Market Trends

Report ID: GMI9707 Published Date: May 2024Report Format: PDF
Download Free Sample
Summary
Table of Content

Liver Cancer Drugs Market Trends

The market is witnessing expansion driven by increasing investments in research and development (R&D) targeting innovative therapies. These investments focused on fostering innovation, have resulted in the discovery of novel treatments with the potential to enhance outcomes for liver cancer patients, thereby fuelling the market growth.

  • For instance, in May 2024, the KWF Dutch Cancer Society allocated more than USD 1 million to the TechMed Centre, University of Twente. This project aimed to explore a novel immunotherapy approach for the treatment of liver cancer, specifically targeting a distinct type of immune cells compared to conventional methods. Thus, this investment aimed to bolstered research endeavors, paving the way for an expansion in therapeutic options for liver cancer treatment, thereby catalyzing market growth.

Moreover, the increasing awareness of early cancer diagnosis and treatment, along with advancements in research technologies for drug delivery further enhances market growth.

Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :

Mention the key players involved in liver cancer drugs industry?+

AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Bristol-Myers Squibb Company, Eisai Co., Ltd., Exelixis, Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc, Novartis AG, Sanofi SA, and Thermo Fisher Scientific Inc.

How big is the North America liver cancer drugs industry?+

North America liver cancer drugs market size exceeded USD 1.1 billion in 2023, attributed to the early adoption of advanced diagnostic tests and therapies for liver cancer.

Why is the use of hepatocellular carcinoma drugs rising?+

The hepatocellular carcinoma segment in the liver cancer drugs market generated USD 1.9 billion in 2023 and is predicted to reach USD 5 billion by 2032, due to its prevalence among individuals with chronic liver diseases such as cirrhosis.

What is the size of the liver cancer drugs market?+

The market size of liver cancer drugs was reached USD 2.9 billion in 2023 and is estimated to grow at 11.8% CAGR from 2024 to 2032, owing to the rising incidence of liver cancer.

Liver Cancer Drugs Market Scope

Related Reports

Buy Now

Buy Now

Premium Report Details

Download Free Sample